115. The Yeasts: PCP/Pneumocytis jirovecii

BIOCIDES ARE COMING FOR YOU. Find out what they are, what the benefits and harms they have, and what we can do to control their use in consumer products. This was a fascinating, wide-ranging discussion on the use of agents that can affect the human/animal microbiome and environme ...  Show more

Flustered by fluconazole? An ignoramus on itraconazole and isavuconazole?Puzzled by Posa? VEXED BY VORI? Never fear: You can be amazed at the Azoles, just learn how to use 'em right! That's what this episode's all about! Alyssa and Jame UNITE in the first of our episodes on antif ...  Show more

This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ...

This week, we kick off a new series focusing on diffuse large B-cell lymphoma. In this first episode, we discuss the basics that everyone needs to understand before diving into the management of this disease.

This week, we kick off a new series focusing on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this first episode, we discuss the alphabet soup of premalignant hematologic conditions including CHIP, CCUS, and ICUS, before moving onto MDS and AML in future ...

By popular demand, our next series that we are excited to share with you is on MDS/AML! As we prepare for the release of the first episode next week, let’s throw it back to Episode 019 in our Heme/Onc Emergencies Series and talk about APL!

Episode contents:

- How ...